Figure 3From: Repeated intranasal TLR7 stimulation reduces allergen responsiveness in allergic rhinitisMean plasma levels of AZD8848’s acid metabolite from the first group of the repeat challenge/treatment study after administration of 60 μg of the study drug. The metabolite increased rapidly and returned to baseline levels after four hours.Back to article page